Drug intelligence / Profile preview

(1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate

Development stage
Unknown
Modality
Small Molecules
01

Overview

(1S)-2‑oxo‑1‑phenyl‑2‑[(1,3,4‑trioxo‑1,2,3,4‑tetrahydroisoquinolin‑5‑yl)amino]ethyl acetate is a small molecule experimental compound with the molecular formula C19H14N2O6 and a molecular weight of approximately 366.32 g/mol. It is structurally characterized as an isoquinoline derivative with multiple oxo groups and an acetoxy substituent. The drug has been identified in research databases but does not have an established clinical use or approved indication. Mechanistically it has been reported to interact with caspase‐3—a key executioner protease in the apoptosis pathway—suggesting potential utility as a modulator of programmed cell death[1][9]. However its precise mechanism of action pharmacological profile and therapeutic applications remain largely uncharacterized in public sources.

Other names
(S)-phenyl[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5‑yl)carbamoyl]methyl acetate
02

Targets

CASP3 (Caspase-3)

Beyond the preview

Go deeper on (1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on (1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call